| Description |
1 online resource (xxxvii, 245 pages) : illustrations |
| Series |
Woodhead Publishing Series in biomedicine ; no. 43 |
|
Woodhead Publishing series in biomedicine ; no. 43.
|
| Contents |
1. Introduction to the biopharmaceutical market -- 2. Synopsis of theories of the firm and valuation methods -- 3. Innovation and the merging of the pharmaceutical and biotechnology industries -- 4. The funding of basic research and public-private partnerships -- 5. Strategic alliances -- 6. Angel and venture capital -- 7. The initial public offering -- 8. Conclusion |
| Summary |
This book describes the theoretical underpinnings, present practice, and trends in R & D funding in the human biopharmaceutical market sector, both in the U.S. and worldwide. It includes a review and discussion of public-private partnership activity and their inner-workings as well as an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It includes venture capital activity and the IPO process |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Pharmaceutical industry -- Finance
|
|
Biopharmaceutics -- Research
|
|
Biopharmaceutics -- economics
|
|
Biomedical Research
|
|
Drug Discovery -- economics
|
|
Drug Industry -- economics
|
|
Pharmaceutical industry -- Finance
|
| Form |
Electronic book
|
| ISBN |
9781908818386 |
|
1908818387 |
|
9781306177061 |
|
1306177065 |
|
